W

Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Business Management
Share
Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.

Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

Are AMD and Broadcom the real winners of the Nvidia spy scandal?

The chip makers’ shares were posting big gains Monday — but those companies could also be subject to greater scrutiny over their sales practices, analysts say.…

Think the bond market is broken? History says a massive turnaround could be coming.

Bond investors would do well to remember that it’s often darkest before the dawn. Source：MarketWatch

Mercado Bitcoin begins post-hack reopening without a timeline for withdrawals

Customers can view their prehack balances as access returns in phases. The exchange has yet to say when withdrawals will resume. Source：Cointelegraph

Hot U.S. inflation hasn’t cooled off. Rising consumer prices to keep Fed rate hike on track.

Rising prices point to the Fed increasing borrowing costs before Christmas. Source：MarketWatch

Source：https://www.marketwatch.com/story/eli-lilly-is-suing-pharmacies-and-peptide-vendors-over-sales-of-the-next-big-weight-loss-drug-retatrutide-22434cce